Cite
HARVARD Citation
Yau, T. et al. (n.d.). 199TiPPhase III (COSMIC-312) study of cabozantinib (C) in combination with atezolizumab (A) vs sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (aHCC) who have not received previous systemic anticancer therapy. Annals of oncology. p. . [Online].